Safety of Paclitaxel-Coated Balloon Angioplasty for Femoropopliteal Peripheral Artery Disease | JACC: Cardiovascular Interventions
Materials technology in drug eluting balloons: Current and future perspectives - ScienceDirect
Lutonix: Drug Coated Balloons (DCB) for Angioplasties - Lutonix
Atherectomy and Drug-Coated Balloon Angioplasty for the Treatment of Long Infrapopliteal Lesions: A Randomized Controlled Trial | Circulation: Cardiovascular Interventions
Ranger™ - Boston Scientific
Drug-coated balloons: Technical and clinical progress - Huiying Ang, Tobias R Koppara, Salvatore Cassese, Jaryl Ng, Michael Joner, Nicolas Foin, 2020
New BARD LX3513051205F Lutonix 035 Drug Coated Balloon PTA Catheter, 5.0mm x 120mm (X) Disposables - General For Sale - DOTmed Listing #3638805:
U.S. Drug-Coated Balloons Market Threatened by Reimbursement Cuts and | mddionline.com
What are the Pathological Concerns and Limitations of Current Drug-coated Balloon Technology? – touchCARDIO
Intrinsic coating morphology modulates acute drug transfer in drug-coated balloon therapy | Scientific Reports
Drug-eluting Balloons Enter the U.S. Market | DAIC
Bard's Drug-Coated Angioplasty Balloon Continues to Show Efficacy | mddionline.com
CMS Approves Pass-Through Payment for Lutonix Drug-eluting Balloon for Outpatient Use | DAIC
INVAMED Research & Development | EXTENDER PTCA Drug Released Coronary Balloon